GET DAILY SIGNALSCelestica (CLS) Q2 2026 Earnings: Watching for Reaffirmation After -35% Drop
Key Takeaways
- Celestica reports Q2 2026 results after market close on Monday, July 27, with a conference call scheduled for 8:00 a.m. ET on July 28.
- Consensus estimates point to adjusted EPS of approximately $2.29 on revenue of $4.35 billion, representing year-over-year growth of roughly 65% and 50%, respectively.
- Company-issued guidance calls for revenue of $4.15 billion to $4.45 billion and adjusted EPS of $2.14 to $2.34, with an adjusted operating margin of approximately 8.0% at the midpoint.
- CLS shares have fallen roughly 35% from their June 2026 high of $474.03, closing at $305.28 on July 24, intensifying scrutiny on whether Q2 results can reaffirm the AI-driven growth narrative.
- Investor focus centers on the Connectivity and Cloud Solutions (CCS) segment, which surged 76% year-over-year in Q1 2026, driven by hyperscaler demand for networking and compute infrastructure.
- Full-year 2026 guidance was raised to $19.0 billion in revenue and $10.15 in adjusted EPS following the Q1 report, setting a high bar for the second-half trajectory.
Why This Earnings Report Matters
Celestica's Q2 2026 report arrives at a critical juncture for the company and the broader AI infrastructure theme. The Toronto-based electronics manufacturing services provider has become one of the more direct plays on hyperscaler spending for data centers, with its CCS segment delivering strong growth over the past year. After lifting its full-year 2026 outlook to $19.0 billion in revenue in April, the company now needs to show that the raised targets remain achievable amid questions about the durability of AI-related capex. With CLS shares down 35% from the June peak, the upcoming print offers a timely check on enterprise and cloud demand trends.
Consensus Estimates and Company Guidance
Wall Street expectations are elevated heading into the report. The Zacks Consensus Estimate calls for adjusted EPS of $2.29 on revenue of $4.35 billion, which would represent year-over-year growth of about 65% on the bottom line and 50% on the top line. Celestica's own guidance, provided with the Q1 results on April 27, projects revenue between $4.15 billion and $4.45 billion and adjusted EPS between $2.14 and $2.34, with adjusted operating margin expected near 8.0% at the midpoint.
In Q1 2026 the company posted revenue of $4.05 billion and adjusted EPS of $2.16, beating the high end of its EPS range. The CCS segment generated $3.24 billion, up 76% year-over-year, while the ATS segment contributed $0.81 billion and was essentially flat. Analysts expect CCS to continue driving growth in Q2, with segment revenue consensus around $3.58 billion. Over the past four quarters CLS has delivered an average earnings surprise of roughly 8%.
To compare CLS with peers in the space, I also checked this using Tickeron’s AI Screener to see how the stock stacks up on key metrics.
Stock Performance and Market Sentiment
Investor caution is evident in the recent price action. CLS closed at $305.28 on July 24, down 35% from its 52-week high of $474.03 reached on June 2. The decline reflects both a broader pullback in high-momentum AI names and specific concerns, including the planned increase in 2026 capital expenditures to approximately $1 billion from an earlier $400 million budget. This has raised questions about free cash flow and margin trends in the near term.
The pullback has brought the forward P/E ratio down to around 32 times, below earlier levels above 40 but still above the historical average. Customer concentration is another point of focus, with three customers accounting for roughly 36%, 15%, and 12% of revenue. Any signs of softening demand from these accounts could weigh on the stock, while a beat-and-raise outcome that supports the $19.0 billion annual target could provide relief, especially given the current technical setup.
Forward Outlook and Areas to Monitor
Beyond the headline numbers, several forward indicators will shape the outlook for the balance of 2026 and into 2027.
Full-Year Guidance. The key question is whether management reaffirms, raises, or reduces the $19.0 billion revenue and $10.15 adjusted EPS targets. The Street has already incorporated the April increase, so any downward revision, particularly in the CCS enterprise vertical, would likely draw scrutiny.
CCS Segment and Hyperscaler Trends. The CCS segment remains the main growth driver. Commentary on order pipelines, 800G Ethernet switch adoption, and new networking wins will be closely watched. With major hyperscalers such as Google targeting around $80 billion in annual capex, the ability to convert demand into backlog matters. Investors will also note any updates on supply chain or production timeline risks highlighted in the Q1 call.
Margin and Capex Dynamics. The ramp in capital expenditures to $1 billion is substantial. The market will look for evidence that adjusted operating margin can hold near the 8.0% target and that the $500 million free cash flow target for the year remains intact.
ATS Segment. While secondary to CCS, any stabilization or improvement in HealthTech, industrial, and capital equipment markets could broaden the growth story and lessen dependence on the CCS segment.
My Approach to Research
When preparing for earnings like this one, I frequently use Tickeron’s AI Screener to quickly filter names in the AI infrastructure space by technical patterns, fundamentals, and trend strength. It helps surface comparable ideas without spending hours on manual screens and has become a regular part of my workflow for staying on top of momentum names.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.
CLS's RSI Indicator climbs out of oversold territory
The RSI Oscillator for CLS moved out of oversold territory on November 09, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 19 similar instances when the indicator left oversold territory. In 17 of the 19 cases the stock moved higher. This puts the odds of a move higher at 89%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +8.33% 3-day Advance, the price is estimated to grow further. Considering data from situations where CLS advanced for three days, in 310 of 370 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
CLS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 08, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CLS as a result. In 63 of 80 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 79%.
The Moving Average Convergence Divergence Histogram (MACD) for CLS turned negative on October 09, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 49 similar instances when the indicator turned negative. In 38 of the 49 cases the stock turned lower in the days that followed. This puts the odds of success at 78%.
CLS moved below its 50-day moving average on October 14, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for CLS crossed bearishly below the 50-day moving average on October 21, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 10 of 12 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 83%.
The 50-day moving average for CLS moved below the 200-day moving average on October 15, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CLS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 75%.
The Aroon Indicator for CLS entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron SMR rating for this company is 20 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 51 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 73, placing this stock slightly better than average.
The Tickeron Valuation Rating of 66 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: CLS's P/B Ratio (10.512) is slightly higher than the industry average of (3.856). P/E Ratio (21.331) is within average values for comparable stocks, (6.228). CLS's Projected Growth (PEG Ratio) (0.030) is slightly lower than the industry average of (0.930). Dividend Yield (0.000) settles around the average of (0.021) among similar stocks. P/S Ratio (2.388) is also within normal values, averaging (4.422).
The Tickeron Price Growth Rating for this company is 85 (best 1 - 100 worst), indicating slightly worse than average price growth. CLS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 94 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a provider of electronics manufacturing services
Industry ElectronicComponents
Advertisement